GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3926 - 3950 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgM Patient 3 11 mild
G96865DJ
39871
IgM Patient 3 4 mild
G96865DJ
42242
IgA Patient 4 12 mild
G96865DJ
757
IgG Patient 4 12 mild
G96865DJ
1236
IgM Patient 4 12 mild
G96865DJ
1216
IgA Patient 1 10 moderate
G96881BQ
331
IgA Patient 1 22 moderate
G96881BQ
370
IgA Patient 1 6 moderate
G96881BQ
316
IgG Patient 1 10 moderate
G96881BQ
21
IgG Patient 1 22 moderate
G96881BQ
25
IgM Patient 1 10 moderate
G96881BQ
30
IgM Patient 1 22 moderate
G96881BQ
52
IgG Patient 1 6 moderate
G96881BQ
26
IgM Patient 1 6 moderate
G96881BQ
27
IgA Patient 2 15 mild
G96881BQ
272
IgA Patient 2 24 mild
G96881BQ
298
IgG Patient 2 15 mild
G96881BQ
24
IgG Patient 2 24 mild
G96881BQ
29
IgM Patient 2 15 mild
G96881BQ
39
IgA Patient 2 3 mild
G96881BQ
272
IgG Patient 2 3 mild
G96881BQ
26
IgM Patient 2 24 mild
G96881BQ
51
IgM Patient 2 3 mild
G96881BQ
45
IgA Patient 3 -180 mild
G96881BQ
277
IgA Patient 3 11 mild
G96881BQ
389

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024